• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用[68Ga]乙二胺四乙酸和正电子发射断层扫描检查阿尔茨海默型痴呆患者的血脑屏障通透性。

Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography.

作者信息

Schlageter N L, Carson R E, Rapoport S I

出版信息

J Cereb Blood Flow Metab. 1987 Feb;7(1):1-8. doi: 10.1038/jcbfm.1987.1.

DOI:10.1038/jcbfm.1987.1
PMID:3100543
Abstract

Positron emission tomography with [68Ga]ethylenediaminetetraacetic acid ([68Ga]EDTA) was used to examine the integrity of the blood-brain barrier (BBB) in five patients with dementia of the Alzheimer type and in five healthy age-matched controls. Within a scanning time of 90 min, there was no evidence that measurable intravascular tracer entered the brain in either the dementia or the control group. An upper limit for the cerebrovascular permeability-surface area product of [68Ga]EDTA was estimated as 2 X 10(-6) s-1 in both groups. The results provide no evidence for breakdown of the BBB in patients with dementia of the Alzheimer type.

摘要

采用[68Ga]乙二胺四乙酸([68Ga]EDTA)正电子发射断层扫描技术,对5例阿尔茨海默型痴呆患者及5名年龄匹配的健康对照者的血脑屏障(BBB)完整性进行了检测。在90分钟的扫描时间内,无论是痴呆组还是对照组,均未发现有可测量的血管内示踪剂进入脑内的证据。两组中[68Ga]EDTA的脑血管通透表面积乘积上限估计均为2×10^(-6) s^(-1)。结果表明,阿尔茨海默型痴呆患者不存在血脑屏障破坏的证据。

相似文献

1
Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography.用[68Ga]乙二胺四乙酸和正电子发射断层扫描检查阿尔茨海默型痴呆患者的血脑屏障通透性。
J Cereb Blood Flow Metab. 1987 Feb;7(1):1-8. doi: 10.1038/jcbfm.1987.1.
2
Measurement of blood-brain barrier permeability with positron emission tomography and [68Ga]EDTA.正电子发射断层扫描术和[68Ga]乙二胺四乙酸用于测量血脑屏障通透性
J Cereb Blood Flow Metab. 1984 Sep;4(3):323-8. doi: 10.1038/jcbfm.1984.48.
3
Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.正电子发射断层扫描与计算机断层扫描在复发性或残留性胶质瘤与治疗引起的脑病变鉴别诊断中的应用
Acta Radiol. 1989 Mar-Apr;30(2):121-8.
4
A kinetic evaluation of blood-brain barrier permeability in human brain tumors with [68Ga]EDTA and positron computed tomography.利用[68Ga]乙二胺四乙酸和正电子计算机断层扫描对人脑肿瘤血脑屏障通透性进行动力学评估。
J Cereb Blood Flow Metab. 1984 Dec;4(4):507-15. doi: 10.1038/jcbfm.1984.75.
5
Simplified, noninvasive PET measurement of blood-brain barrier permeability.简化的、无创的正电子发射断层扫描(PET)测量血脑屏障通透性
J Comput Assist Tomogr. 1987 May-Jun;11(3):390-7. doi: 10.1097/00004728-198705000-00004.
6
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography.使用68镓-乙二胺四乙酸和正电子发射断层扫描对多发性硬化症血脑屏障通透性进行定量评估。
J Neurol Neurosurg Psychiatry. 1988 Aug;51(8):1058-62. doi: 10.1136/jnnp.51.8.1058.
7
Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.正常成年小鼠和阿尔茨海默病双转基因小鼠模型中血脑屏障处蛋白质的通透性。
Neurobiol Dis. 2001 Aug;8(4):555-67. doi: 10.1006/nbdi.2001.0402.
8
Positron emission tomography with 68Ga-EDTA compared with transmission computed tomography in the evaluation of brain infarcts.68Ga-EDTA正电子发射断层扫描与透射计算机断层扫描在脑梗死评估中的比较
Acta Radiol Diagn (Stockh). 1981;22(4):385-98. doi: 10.1177/028418518102200401.
9
Blood-brain barrier to ammonia in humans.人类血脑屏障对氨的作用
J Cereb Blood Flow Metab. 1984 Dec;4(4):516-22. doi: 10.1038/jcbfm.1984.76.
10
Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography.使用铷-82和正电子发射断层扫描定量测量血脑屏障通透性。
J Cereb Blood Flow Metab. 1984 Dec;4(4):535-45. doi: 10.1038/jcbfm.1984.78.

引用本文的文献

1
Manganese-Induced Parkinsonism: A Review of Etiologies and Treatments.锰诱导的帕金森综合征:病因与治疗综述
Degener Neurol Neuromuscul Dis. 2025 Jun 6;15:65-79. doi: 10.2147/DNND.S482018. eCollection 2025.
2
Nanotechnology to Overcome Blood-Brain Barrier Permeability and Damage in Neurodegenerative Diseases.纳米技术克服神经退行性疾病中的血脑屏障通透性及损伤
Pharmaceutics. 2025 Feb 20;17(3):281. doi: 10.3390/pharmaceutics17030281.
3
Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier.
双特异性治疗性抗体通过血脑屏障的受体介导药物递送
Front Drug Deliv. 2023;3. doi: 10.3389/fddev.2023.1227816. Epub 2023 Jul 10.
4
Endothelial Dysfunction in Neurodegenerative Diseases.神经退行性疾病中的血管内皮功能障碍。
Int J Mol Sci. 2023 Feb 2;24(3):2909. doi: 10.3390/ijms24032909.
5
The Impairment of Blood-Brain Barrier in Alzheimer's Disease: Challenges and Opportunities with Stem Cells.阿尔茨海默病中的血脑屏障损伤:干细胞面临的挑战与机遇。
Int J Mol Sci. 2022 Sep 4;23(17):10136. doi: 10.3390/ijms231710136.
6
Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.Wnt/β-连环蛋白通路的激活可减轻阿尔茨海默病的血脑屏障功能障碍。
Brain. 2022 Dec 19;145(12):4474-4488. doi: 10.1093/brain/awac236.
7
Imaging subtle leaks in the blood-brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions.在衰老的人脑血脑屏障中检测细微渗漏:潜在的陷阱、挑战和可能的解决方案。
Geroscience. 2022 Jun;44(3):1339-1351. doi: 10.1007/s11357-022-00571-x. Epub 2022 Apr 25.
8
Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease.血脑屏障与人类认知障碍及阿尔茨海默病的关联。
Nat Cardiovasc Res. 2022 Feb;1(2):108-115. doi: 10.1038/s44161-021-00014-4. Epub 2022 Feb 7.
9
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.阿尔茨海默病中的血脑屏障渗漏:从发现到临床相关性。
Pharmacol Ther. 2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30.
10
Tracer kinetic assessment of blood-brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors.脑小血管病血脑屏障渗漏和血容量的示踪动力学评估:与疾病负担和血管危险因素的关系。
Neuroimage Clin. 2021;32:102883. doi: 10.1016/j.nicl.2021.102883. Epub 2021 Nov 17.